Biotinylated Human APRIL / TNFSF13 Protein, Avitag™,His Tag, active trimer (MALS verified)

Customer Reviews
Cat. No. / Size
Price
Qty
APL-H82Q8-25ug
€360.00
APL-H82Q8-200ug
€1585.00
ETA of in-stock products:3 business days

Product Details

  • Synonym

    APRIL, TNFSF13, TALL-2, TRDL-1, CD256, TALL2, ZTNF2

  • Source

    Biotinylated Human APRIL Protein, Avitag,His Tag (APL-H82Q8) is expressed from human 293 cells (HEK293). It contains AA Gln 111 - Leu 250 (Accession # O75888-1).

    Predicted N-terminus: Gly

  • Molecular Characterization

    This protein carries an Avi tag (Avitag™) at the N-terminus, followed by a polyhistidine tag.

    The protein has a calculated MW of 50.9 kDa. The protein migrates as 55-63 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Purity

    >90% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    APRIL SDS-PAGE

    Biotinylated Human APRIL Protein, Avitag,His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    APRIL SEC-MALS

    The purity of Biotinylated Human APRIL Protein, Avitag,His Tag (Cat. No. APL-H82Q8) is more than 90% and the molecular weight of this protein is around 50-80 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     APRIL ELISA

    Immobilized Biotinylated Human APRIL Protein, Avitag,His Tag (Cat. No. APL-H82Q8) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Human BCMA, Fc Tag, premium grade (Cat. No. BC7-H5254) with a linear range of 0.1-2 ng/mL (QC tested).

    Protocol
  •  APRIL ELISA

    Immobilized Biotinylated Human APRIL Protein, Avitag,His Tag (Cat. No. APL-H82Q8) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Human TACI (R119A, R122A), Fc Tag (Cat. No. TAI-H5253) with a linear range of 2-39 ng/mL (Routinely tested).

    Protocol

Customer Reviews
Writing Reviews

Background

APRIL(a proliferation-inducing ligand) is also known as Tumor necrosis factor ligand superfamily member 13, TALL-2, TRDL-1, CD256, TNFSF13, cytokine that binds to TNFRSF13B/TACI and to TNFRSF17/BCMA. APRIL is a cytokine of the tumor necrosis factor family associated mainly with hematologic malignancies. The closely related TNF family ligands B cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) serve in the generation and maintenance of mature B-lymphocytes. Both BAFF and APRIL assemble as homotrimers that bind and activate several receptors that they partially share. BAFF-APRIL heteromers of different stoichiometries have distinct receptor-binding properties and activities. In addition, expression of APRIL was regulated by miR-145 in GC cells.

Recent Advances

 
Drug Development Progress
  • English Name:

    Tumor necrosis factor ligand superfamily member 13

  • Category:

  • Approved Drugs:

    2 Details

  • Drugs in Clinical Trials:

    30 Details

  • Highest Development Stage:

    Approved

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background